2.0
2. Juli 2020
Ehemaliger Mitarbeiter, mehr als 10 Jahre
South San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Father of BioOncology. Created targeted oncology and hematology products that changed the course of the disease.
Kontras
Will never be DNA again. Massive layoffs of long term highly skilled employees over the past six years (60+%). The departure of early and late-stage researchers has impacted future opportunities. They "don't need people managers." Little to no support from HR for retaliation and bad managers. No exit interviews. No action is taken to protect employees—multiple civil suits.